advertisement
11.3.4 Betablocker (7)
Showing records 1 to 7
Display all abstracts in classification 11.3.4 Betablocker
Search within classification 11.3.4 Betablocker24420 Cytochrome oxidase 2D6 gene polymorphism in primary open-angle glaucoma with various effects to ophthalmic timolol
Yang Y; Wu K; Yuan H; Yu M
Journal of Ocular Pharmacology and Therapeutics 2009; 25: 163-171
24021 Assessing the efficacy of latanoprost vs timolol using an alternate efficacy parameter: the intervisit intraocular pressure range
Varma R; Hwang LJ; Grunden JW; Bean GW; Sultan MB
American Journal of Ophthalmology 2009; 148: 221-226
24344 A comparison of the long-term effects of dorzolamide 2% and brinzolamide 1%, each added to timolol 0.5%, on retrobulbar Hemodynamics and Intraocular Pressure in Open-Angle Glaucoma Patients
Martinez A; Sanchez-Salorio M
Journal of Ocular Pharmacology and Therapeutics 2009; 25: 239-248
24515 Topical Beta Blockers in Asthmatic Patients-Is It Safe?
Kaiserman I; Fendyur A; Vinker S
Current Eye Research 2009; 34: 517-522
24141 Use of antihypertensive medications and topical beta-blockers and the long-term incidence of cataract and cataract surgery
Kanthan GL; Wang JJ; Rochtchina E; Mitchell P
British Journal of Ophthalmology 2009; 93: 1210-1214
24157 Evaluation of risk of falls and orthostatic hypotension in older, long-term topical beta-blocker users
Ramdas WD; van der Velde N; van der Cammen TJ; Wolfs RC
Graefe's Archive for Clinical and Experimental Ophthalmology 2009; 247: 1235-1241
24270 The effect of travoprost 0.004% as an adjuvant to timolol 0.5% therapy
Kovacic Z; Stanic R; Rogosic V; Bojic L; Ivanisevic M; Capkun V
Acta Clinica Croatica, Supplement 2009; 48: 31-33